Security key
29273B302
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA)
CUSIP: 29273B302
Q1 2023 13F Holders as of 31 Mar 2023
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 1,186,300
- Total 13F shares
- 167,908
- Share change
- -4,409
- Total reported value
- $384,072
- Price per share
- $2.29
- Number of holders
- 12
- Value change
- -$14,082
- Number of buys
- 6
- Number of sells
- 4
Report period
Q1 2023
Institutions
12
Top holders
10
NDRA full security history
Newer quarter: Q2 2023
Previous quarter: Q4 2022
ENDRA Life Sciences Inc. SEC filings
ENDRA Life Sciences Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 29273B302
Recent filing periods:
Top shareholders of NDRA - ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
4.2%
|
49,881
|
$203,016 | — | 31 Dec 2022 | |
| MORGAN STANLEY |
13F
|
Company |
3.6%
|
43,228
|
$175,938 | — | 31 Dec 2022 | |
| NewEdge Advisors, LLC |
13F
|
Company |
2.8%
|
32,841
|
$134 | — | 31 Dec 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.6%
|
19,202
|
$78,000 | — | 31 Dec 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.3%
|
15,432
|
$63,000 | — | 31 Dec 2022 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.38%
|
4,515
|
$18,000 | — | 31 Dec 2022 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.37%
|
4,444
|
$18,000 | — | 31 Dec 2022 | |
| UBS Group AG |
13F
|
Company |
0.18%
|
2,150
|
$8,751 | — | 31 Dec 2022 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.06%
|
766
|
$3,000 | — | 31 Dec 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.01%
|
102
|
$415 | — | 31 Dec 2022 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
22
|
$90 | — | 31 Dec 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
6
|
$24 | — | 31 Dec 2022 | |
| Worth Asset Management, LLC |
13F
|
Company |
—
class O/S missing
|
270
|
$1,099 | — | 31 Dec 2022 | |
| Renaud Bertrand Maloberti |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
186,430
|
— | — | 28 Mar 2022 | |
| Francois Roger Michelon |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
69,531
|
— | — | 30 Jan 2023 | |
| Irina Pestrikova |
3/4/5
|
Senior Director, Finance |
—
class O/S missing
|
8,000
|
— | — | 30 Jan 2023 |
Institutional Holders of ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) as of Q1 2023
As of 31 Mar 2023,
ENDRA Life Sciences Inc. - Common Stock, par value $0.0001 per share (NDRA) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
167,908 shares.
The largest 10 holders included
VANGUARD GROUP INC, NewEdge Advisors, LLC, MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, DIMENSIONAL FUND ADVISORS LP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, JPMORGAN CHASE & CO, ADVISOR GROUP HOLDINGS, INC., Royal Bank of Canada, and Cranbrook Wealth Management, LLC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2023 vs Q4 2022 Across Filers
Q4 2022 holders
11
Q1 2023 holders
12
Holder diff
1
| Investor | Q4 2022 Shares | Q1 2023 Shares | Share Diff | Share Chg % | Q4 2022 Value $ | Q1 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.